Myriad Genetics Stock Target Price and Analyst Consensus
| MYGN Stock | USD 12.39 0.13 1.04% |
The current analyst and expert consensus on Myriad Genetics is Buy with 6 hold recommendations. The current projected Myriad Genetics target price consensus is 21.20 with 15 analyst opinions. One of the most common ways Myriad Genetics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Myriad Genetics vendors, executives, and/or customers. Myriad Genetics recommendation module provides expert sentiment on the projected Myriad Genetics target price to derive its highest and lowest estimates based on target price standard deviation of 3.302.
Lowest Forecast 19.29 | Highest Forecast 23.53 | Target Price 21.2 |
Myriad |
It's important to approach Myriad Genetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Myriad Genetics Target Price Consensus
Myriad target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Myriad Genetics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 15 | Buy |
Most Myriad analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Myriad stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Myriad Genetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMyriad Genetics Target Price Projection
Myriad Genetics' current and average target prices are 12.39 and 21.20, respectively. The current price of Myriad Genetics is the price at which Myriad Genetics is currently trading. On the other hand, Myriad Genetics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Myriad Genetics Market Quote on 18th of January 2025
Target Price
Analyst Consensus On Myriad Genetics Target Price
Myriad Genetics Analyst Ratings
Myriad Genetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Myriad Genetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Myriad Genetics' financials, market performance, and future outlook by experienced professionals. Myriad Genetics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Myriad Genetics price targets
Myriad Genetics' stock target price is an estimate of its future price, usually made by analysts. Using Myriad Genetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Myriad Genetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Myriad Genetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Myriad Genetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Myriad Genetics is a key component of Myriad Genetics valuation and have some predictive power on the future returns of a Myriad Genetics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | USD Crypto Fund Invested less than 1 share | |
 | Macroaxis Index Invested over 10K shares | |
 | Manufacturing Invested over 40 shares | |
 | Warren Buffett Holdings Invested over 40 shares |
Check out Macroaxis Advice on Myriad Genetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.